ABUS
Arbutus Biopharma Corp
+0.02 (+0.40%)5.07USD1.2M成交股數–市值–本益比(近四季)–股價營收比-90.6%營收年增(近四季)2026-11-16下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。外國發行人(20-F)通常只申報半年或年度,逐季會有缺。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 1.0M-91% | 179M+10055% | 1.1M-22% | 529K-69% | 10.7M+601% | 1.8M-18% | 1.3M-71% | 1.7M-63% | 1.5M | 2.1M | 4.7M | 4.7M |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 2.9M | 4.1M | 5.0M | 5.8M | 5.5M | 9.0M | 14.3M | 15.6M | 15.4M | 17.6M | 20.2M | 17.7M |
| 銷售管理費用 | 3.9M | 5.9M | 3.7M | 3.0M | 3.3M | 5.8M | 4.5M | 7.5M | 5.3M | 5.1M | 5.8M | 6.0M |
| 營業利益 | −6.0M-501% | 169M-757% | −5.3M-75% | −8.7M-60% | 1.5M-108% | −25.7M+24% | −21.4M-1% | −21.6M+17% | −19.4M | −20.7M | −21.6M | −18.4M |
| 營業利益率 | -588.2% | 94.3% | -503.3% | -1,636.9% | 13.9% | -1,456.9% | -1,601.2% | -1,250.5% | -1,263.9% | -967.2% | -462.8% | -395.3% |
| 稅後淨利 | −5.1M-304% | 170M-792% | −3.8M-81% | −7.7M-61% | 2.5M-114% | −24.5M+27% | −19.7M-2% | −19.8M+16% | −17.9M | −19.3M | −20.1M | −17.1M |
| 淨利率 | -507.2% | 94.7% | -357.4% | -1,463.5% | 23.5% | -1,390.4% | -1,472.5% | -1,146.9% | -1,166.8% | -900.3% | -431.6% | -367.5% |
| 稀釋 EPS | -0.03-400% | 0.87-769% | -0.01-90% | -0.04-64% | 0.01-110% | -0.13+8% | -0.10-17% | -0.11+10% | -0.10 | -0.12 | -0.12 | -0.10 |
| 稀釋股數 | 197M | 195M | 192M | 192M | 192M | 191M | 189M | 188M | 176M | 166M | 168M | 166M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 19.2M | 23.7M | 18.0M | 22.4M | 37.4M | 37.1M | 31.8M | 62.8M | 43.1M | 26.3M | 17.5M | 27.2M |
| 應收帳款 | 369K | 1.3M | 1.4M | 905K | 1.0M | 1.2M | 1.6M | 1.8M | 2.1M | 1.8M | 2.2M | 2.6M |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 274M | 277M | 94.6M | 97.7M | 103M | 117M | 140M | 160M | 150M | 144M | 159M | 177M |
| 有息負債 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 總負債 | 15.3M | 17.0M | 18.0M | 20.3M | 20.3M | 37.9M | 33.6M | 37.6M | 35.7M | 38.4M | 39.3M | 42.1M |
| 股東權益 | 259M | 260M | 76.6M | 77.4M | 83.0M | 79.2M | 107M | 122M | 115M | 106M | 119M | 135M |
| 負債比 | 5.6% | 6.1% | 19.1% | 20.8% | 19.6% | 32.4% | 23.9% | 23.5% | 23.7% | 26.6% | 24.8% | 23.8% |
| 淨現金(現金 − 有息負債) | 19.2M | 23.7M | 18.0M | 22.4M | 37.4M | 37.1M | 31.8M | 62.8M | 43.1M | 26.3M | 17.5M | 27.2M |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −8.1M-39% | – | – | – | −13.4M | – | – | −19.3M | – | – | – |
| 資本支出 | – | – | – | – | – | 0.00 | – | – | 95K | – | – | – |
| 自由現金流 | – | – | – | – | – | −13.4M | – | – | −19.4M | – | – | – |
| 折舊攤銷 | – | 11K | – | – | – | 330K | – | – | 355K | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | -759.1% | – | – | -1,265.7% | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 14.1M
| Reportable | 14.1M | 100.0% | +128.2% |
|---|
產品／服務2025 年度 · 14.1M
| Collaboration And Contracts | 12.6M | 89.5% | +221.5% |
|---|---|---|---|
| Non Cash Royalty | 1.5M | 10.5% | -34.2% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 14.1M | +128.2% | −33.5M | -237.9% | -0.17 | −39.6M |
| FY2024 | 6.2M | -66.0% | −69.9M | -1,133.0% | -0.38 | −65.0M |
| FY2023 | 18.1M | -53.5% | −72.8M | -401.6% | -0.44 | −86.9M |
| FY2022 | 39.0M | +255.1% | −69.5M | -178.0% | -0.46 | −35.9M |
| FY2021 | 11.0M | +58.9% | −76.2M | -693.9% | -0.83 | −68.3M |
| FY2020 | 6.9M | +15.0% | −63.7M | -922.0% | -1.00 | −51.7M |
| FY2019 | 6.0M | +1.1% | −154M | -2,557.4% | -2.89 | −71.6M |
| FY2018 | 5.9M | – | −57.1M | -959.8% | -1.21 | −69.0M |